【ChiCTR1900027222】An East meets West theory of depression: from “Zang Fu” (臟腑) to neuroscience
ChiCTR1900027222
尚未开始
/
/
/
2019-11-05
/
/
抑郁症
An East meets West theory of depression: from “Zang Fu” (臟腑) to neuroscience
An East meets West theory of depression: from “Zang Fu” (臟腑) to neuroscience
350000
To bridge the knowledge gap to understand TCM theories of depression using neurophysiological biomarkers
随机平行对照
其它
we will recruit research associates to randomize the patients by computer software.
Open label
香港理工大學康復科學系
/
90
/
2020-10-16
2021-10-16
/
1. Aged 18-65 years; 2. Gender: females and males; 3. Western diagnosis: Diagnosed to be suffering from current episode of depression by a psychiatrist based on DSM-5 and subject to verification by Structured Clinical Interview for DSM-5 (SCID-5); 4. Baseline score of 12 or higher on the 17-item Hamilton Rating Scale for Depression (HAM-D17) (29); 5. Traditional Chinese medicine diagnosis: Diagnosed to be experienced the syndromes of liver Qi stagnation by International Medicine of Traditional Chinese Medicine; 6. The Montreal Cognitive Assessment (MoCA) of 20 or higher (30, 31); 7. Patients type: Day- and out-patient; 8. Voluntarily agree with the investigation and willing to sign a written informed consent form.；
请登录查看1. Primary diagnosis other than depression; 2. Pregnant or lactating women; 3. Have substance abuse or drug dependence; 4. Acute suicidal or violent behavior; 5. Regular practice of Baduanjin or any kinds of mind-body exercise in the past 6 months (29); 6. Are not able to participant in Baduanjin exercise due to mobility problem.；
请登录查看香港理工大學康復科學系
/
香港理工大學康復科學系的其他临床试验
香港理工大學康復科學系的其他临床试验
最新临床资讯
-
诺华：CFB抑制剂终止狼疮肾炎二期临床
医药笔记2026-10-17
-
泽安生物医药：实体瘤MCE启动一期临床
医药笔记2026-10-17
-
药明康德2026-10-17
-
沃森生物2026-10-16
-
罕见病信息网2026-10-16
-
武警特色医学中心2026-10-16
-
生物经纬2026-10-16
-
良医汇肿瘤资讯2026-10-16
-
BioMed科技2026-10-16
-
蒲公英资讯2026-10-16
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-10-26
-
2026-10-25
-
2026-10-25
-
摩熵咨询 33 51
-
摩熵咨询 20 3
-
摩熵咨询 20 10
-
颁布机构：国家药品审评中心（CDE） 2026-10-16
-
颁布机构：国家药品监督管理局药品审评中心 2026-09-28
-
颁布机构：国家药品监督管理局 2026-09-10
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-10-23
-
2026-10-23
-
2026-10-21
-
摩熵咨询 35 83
-
摩熵咨询 28 71
-
摩熵咨询 34 47
-
颁布机构：国家药品监督管理局 2026-10-19
-
颁布机构：国家市场监督管理总局 2026-10-16
-
颁布机构：国家市场监督管理总局 2026-09-30